Recruiting

Erector Spinae Block

Sponsor:

George Washington University

Code:

NCT05521789

Conditions

Pulmonary Neoplasm

Pulmonary Cancer

Thoracic Diseases

Thoracic Cancer

Thoracic Neoplasms

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ESB Thoracic

Study Details

Brief summary:

The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.

Conditions

Pulmonary Neoplasm

Pulmonary Cancer

Thoracic Diseases

Thoracic Cancer

Thoracic Neoplasms

Study ID

NCT05521789

Start date

Jul 22, 2022

Status verified date

Feb, 2026

Completion date

Jul 21, 2027

Anticipated

Primary completion date

Dec 21, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • pulmonary resection
  • 18<age<90

Exclusion Criteria:

  • pleurodesis
  • decortication
  • emergent surgery
  • local anesthetic allergy
  • intraoperative complication (inadvertent hemorrhage or conversion to open surgery)
  • bilateral pulmonary resection

Study Design

Enrollment

70 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Standard of Care + ESB Thoracic

Patients randomized to this group will receive an erector spinae block in addition to the standard of care treatment

no intervention: Standard of Care

Patients randomized to this group will receive standard of care treatment and NO erector spinae block

Interventions

ESB Thoracic

Erector spinae thoracic block with bupivacaine

Primary outcome measure

  • Outcome Measure - Pain Score and Pain Medications (6 hours) [ Time Frame: At 6 hours postoperatively ]
  • Outcome Measure - Pain Score and Pain Medications (12 hours) [ Time Frame: At 12 hours postoperatively ]
  • Outcome Measure - Pain Score and Pain Medications (24 hours) [ Time Frame: At 24 hours postoperatively ]

Central Contacts and Locations

Central contacts

Eduard Shaykhinurov

2028234259eshaykhinurov@mfa.gwu.edu

Locations

The George Washington University

Recruiting

Washington D.C., District of Columbia, United States, 20037

Contacts

Anita Vincent

202-823-4228acucchiaro@mfa.gwu.edu

Eduard Shaykhinurov

2028234259eshaykhinurov@mfa.gwu.edu

Principal Investigator:

Anita Vincent, MD

More Information

Sponsor

George Washington University

Last update posted

Feb 25, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by George Washington University on 2026-02-25.